Androgen receptor levels in prostate cancer epithelial and peritumoral stromal cells identify non-organ confined disease

The Prostate
Carmela RicciardelliWayne Tilley

Abstract

Although up to 30% of men who undergo radical prostatectomy for clinically organ-confined prostate cancer will relapse with disseminated disease, currently it is not possible to predict these patients. Androgen receptor (AR) immunoreactivity in stromal and epithelial compartments of tumor foci was evaluated by video image analysis in 53 radical prostatectomy specimens. Kaplan-Meier and Cox Regression analyses were used to determine whether AR immunostaining was related to rate and risk of relapse, respectively. Ninety-eight percent (52/53) of the tumors contained AR positive malignant epithelial cells. Kaplan-Meier analysis indicated that patients with high AR levels (>64% AR positive nuclear area) in the malignant epithelial cells or low AR levels (<or=45% AR positive nuclear area) in the peritumoral stroma cells, were more likely to relapse earlier following radical prostatectomy. The shortest time to relapse and the highest relapse rate was for patients with both high AR in the malignant epithelial cells and low AR in the peritumoral stromal cells. These findings suggest that AR is an important determinant of disease relapse in early stage prostate cancer, and that altered AR levels in the malignant epithelial cells or in th...Continue Reading

References

May 10, 1991·International Journal of Cancer. Journal International Du Cancer·T H van der KwastJ Trapman
Aug 1, 1987·Endocrine Reviews·G R CunhaY Sugimura
Jan 15, 1997·Journal of the National Cancer Institute·D Feldman
Apr 1, 1997·Proceedings of the National Academy of Sciences of the United States of America·E GiovannucciP W Kantoff
Feb 9, 1999·Vitamins and Hormones·J M Kokontis, S Liao
Feb 9, 1999·Vitamins and Hormones·A K RoyB Chatterjee
Mar 19, 1999·The Journal of Urology·S D SweatD G Bostwick
Jun 26, 1999·Science·D ChenM R Stallcup
Aug 24, 1999·Cancer Metastasis Reviews·D R Rowley
Sep 6, 2001·Proceedings of the National Academy of Sciences of the United States of America·M StanbroughS P Balk
Feb 22, 2002·The Journal of Biological Chemistry·David J MulhollandColleen C Nelson
Jun 28, 2002·Cancer Metastasis Reviews·G BuchananW D Tilley
Aug 20, 2002·Proceedings of the National Academy of Sciences of the United States of America·Peter S NelsonBiaoyang Lin
Sep 19, 2002·Endocrine-related Cancer·Z CuligA Hobisch
Oct 12, 2002·The Journal of Biological Chemistry·Zhigang KangJorma J Palvimo
Dec 20, 2002·The New England Journal of Medicine·Marc J van de VijverRené Bernards
Jan 24, 2003·Nature·Gary Felsenfeld, Mark Groudine
Jan 2, 2004·Nature Medicine·Charlie D ChenCharles L Sawyers

❮ Previous
Next ❯

Citations

Jan 23, 2009·Cancer Metastasis Reviews·Carmela RicciardelliDavid J Horsfall
Nov 22, 2011·Cancer Metastasis Reviews·Paolo Cirri, Paola Chiarugi
Dec 23, 2008·Asian Journal of Andrology·Yi-Nong Niu, Shu-Jie Xia
Dec 24, 2010·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Imtiaz A SiddiquiHasan Mukhtar
Sep 3, 2011·Journal of Carcinogenesis·Peter E Lonergan, Donald J Tindall
Jan 21, 2014·Molecular and Cellular Endocrinology·Damien A LeachGrant Buchanan
Feb 1, 2013·Prostate Cancer·Bi-Dar WangNorman H Lee
May 30, 2014·Endocrine-related Cancer·Cera M NietoScott D Cramer
Sep 2, 2008·Expert Review of Anticancer Therapy·Mary-Ellen Taplin
Feb 1, 2006·Expert Review of Anticancer Therapy·Tsutomu NishiyamaKota Takahashi
Apr 18, 2009·Maturitas·Jin Li, Farook Al-Azzawi
Dec 20, 2008·The Journal of Steroid Biochemistry and Molecular Biology·Germán Rodríguez-GonzálezB Nicolás Díaz-Chico
May 13, 2008·Best Practice & Research. Clinical Endocrinology & Metabolism·James L Mohler
Apr 12, 2008·Molecular and Cellular Endocrinology·Paul A BerryAnne T Collins
Jul 22, 2008·The Journal of Surgical Research·Buckminster FarrowDavid H Berger
Dec 14, 2006·International Journal of Cancer. Journal International Du Cancer·Renée ChmelarNorman M Greenberg
Jun 4, 2010·International Journal of Cancer. Journal International Du Cancer·Miranda P WeenMartin K Oehler
Jan 26, 2012·International Journal of Cancer. Journal International Du Cancer·Vanessa C ThompsonWayne D Tilley
Jan 20, 2010·International Journal of Urology : Official Journal of the Japanese Urological Association·Jun Miki
May 27, 2015·Journal of Ovarian Research·Astrud R TuckTheresa E Hickey
Nov 10, 2009·Seminars in Cell & Developmental Biology·Omar E FrancoSimon W Hayward
Sep 17, 2016·Molecular and Cellular Endocrinology·Damien A LeachGrant Buchanan
Sep 21, 2016·Endocrine-related Cancer·Damien A LeachCharlotte L Bevan
Jan 25, 2017·Cancers·Damien A Leach, Grant Buchanan
Apr 7, 2018·Expert Opinion on Drug Discovery·Achuta Kumar Guddati
Sep 8, 2010·Nature Reviews. Urology·Maria KarlouEleni Efstathiou

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.